文献速递多重用药老年综合评估

老年患者与照护者对药物价值及减处方的看法:一项定性研究

Older Patient and Caregiver Perspectives on Medication Value and Deprescribing: A Qualitative Study.
PubMed 文献 · J Am Geriatr Soc · 2020-02-17

该定性研究通过焦点小组访谈社区居住的65岁以上多重用药患者或照护者,识别影响药物感知价值的关键因素。研究发现感知有效性、对生活质量的不良影响、费用及与处方者的良好关系是主要因素,这些因素影响患者对减处方建议的依从意愿。

要点

  • 感知有效性是患者判定药物高价值的首要因素。
  • 药物若损害生活质量则被视为低价值,费用亦影响价值判断。
  • 与处方者的良好关系比其培训水平更影响药物价值感知。

核心结论

  • 感知有效性、对生活质量的不良影响、费用及与处方者的强关系影响患者和照护者对药物价值的看法。

主要发现

  • 感知有效性是参与者认为药物高价值的主要因素。
  • 药物对生活质量有不良影响时被视为低价值。
  • 费用影响价值判断,尤其当导致物质牺牲时。
  • 参与者重视与处方者的良好关系而非其培训水平。
  • 面对临床情景时,参与者能权衡这些因素并表明是否遵从减处方建议。

临床怎么用

  • 处方者减处方时应围绕感知有效性、生活质量影响、费用及医患关系与老年患者共同决策。
  • 卫生系统可将以患者为中心的价值评估纳入基于系统的减处方干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Shared decision making is essential to deprescribing unnecessary or harmful medications in older adults, yet patients' and caregivers' perspectives on medication value and how this affects their willingness to discontinue a medication are poorly understood. We sought to identify the most significant factors that impact the perceived value of a medication from the perspective of patients and caregivers. DESIGN: Qualitative study using focus groups conducted in September and October 2018. SETTING: Participants from the Pepper Geriatric Research Registry (patients) and the Pitt+Me Registry (caregivers) maintained by the University of Pittsburgh. PARTICIPANTS: Six focus groups of community-dwelling adults aged 65 years or older, or their caregivers, prescribed five or more medications in the preceding 12 months. MEASUREMENTS: We sought to identify (1) general views on medication value and what makes medication worth taking; (2) how specific features such as cost or side effects impact perceived value; and (3) reactions to clinical scenarios related to deprescribing. RESULTS: We identified four themes. Perceived effectiveness was the primary factor that caused participants to consider a medication to be of high value. Participants considered a medication to be of low value if it adversely affected quality of life. Participants also cited cost when determining value, especially if it resulted in material sacrifices. Participants valued medications prescribed by providers with whom they had good relationships rather than valuing level of training. When presented with clinical scenarios, participants ably weighed these factors when determining the value of a medication and indicated whether they would adhere to a deprescribing recommendation. CONCLUSION: We identified that perceived effectiveness, adverse effects on quality of life, cost, and a strong relationship with the prescriber influenced patients' and caregivers' views on medication value. These findings will enable prescribers to engage older patients in shared decision making when deprescribing unnecessary medications and will allow health systems to incorporate patient-centered assessment of value into systems-based deprescribing interventions. J Am Geriatr Soc 68:746-753, 2020.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Pickering AN, Hamm ME, Dawdani A, et al. Older Patient and Caregiver Perspectives on Medication Value and Deprescribing: A Qualitative Study. J Am Geriatr Soc. 2020. PMID: 32067226. doi:10.1111/jgs.16370

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。